Acute Care Volume 23, Issue 9

Medication Safety Alert! May 3, 2018

In this week's issue:

Featured article

Limited regulatory guidance exists for investigational drug labeling, packaging, and nomenclature, exposing sites that participate in clinical trials to many troubling product-related safety risks. Many of these risks are unique to investigational drugs and are less likely to be encountered with US Food and Drug Administration (FDA)-approved medications used outside the research setting. Some of these safety concerns, which were described in detail in Part I in our April 19, 2018 newsletter, include:

  • Look-alike license plate-type identification names during the early phase of research
  • Generi...

Access this Newsletter

Purchasing Options

Purchase access to this individual issue

Purchase a year's access to this bi-weekly publication (25 issues)